Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | dMY Squared Sponsor, LLCDirector, 10% Owner | Derivative conversion | C | — 1.16M sh |
| Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 506.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 21.2K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 506.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Grant or award | A | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 375.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 638.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 440.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Gessert EricaChief Financial Officer | Option exercise | M | — 9,699 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 162.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Hyman JonathanChief Technology Officer | Grant or award | A | — 89.6K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 211.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 125.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | You Harry L.Director, 10% Owner | Grant or award | A | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 125.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 18.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Neagle MatthewChief Operating Officer | Option exercise | M | — 826.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Plaines StephanieDirector | Grant or award | A | — 7,142 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Brown HaydenDirector, President & CEO | Option exercise | M | — 28.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Magnuson WilliamDirector, Chief Executive Officer | Grant or award | A | — 293.9K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Wininger ShaiDirector, President | Grant or award | A | — 180.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 32.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Stewart John REVP - Chief Financial Officer | Tax withholding | F | $10K 643 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | AmundiDirector, 10% Owner | Disposition to issuer | D | — 100.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 47.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 8 | White Daniel JamesDirector | Other acquisition or disposition | J | $8,448 266 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 5 | Bevirt JoeBenDirector, CEO and Chief Architect | Grant or award | A | — 706.4K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 5 | Gessert EricaChief Financial Officer | Option exercise | M | — 8,433 sh | Mar 20, 2026 traded Mar 18, 2026 |